Covid-19 vaccine development and roll-out: Improving transparency and accountability
11 June 2021
How can we reduce secrecy and improve transparency and accountability across the Covid-19 vaccine value chain?
Register for the webinar on WebEx
June 11, 2021:
14.00–15.30 London, UK
15.00–16.30 Berlin, Germany
16.00–17.30 Nairobi, Kenya
09.00–10.30 Washington DC, USA
20.00–21.30 Jakarta, Indonesia
- Till Bruckner, Director of Transparimed
Opportunities and challenges for clinical trial transparency in the context of Covid-19
- Karen Hussmann, U4 Affiliate Expert
- Dr Amaka Vanni, Lecturer in Law, University of Leeds
- Prof Ole F. Norheim, Director of Bergen Centre for Ethics and Priority Setting, University of Bergen, Norway
- Daniela Cepeda Cuadrado, U4 Adviser
- Sarah Steingrüber, U4 Affiliate Expert, Independent Global Health Consultant & Coordinator of the CATCH Alliance
Who is this webinar for?
Health and anti-corruption practitioners, activists, researchers, and policymakers.
Since the outbreak of Covid-19, the medical and scientific communities have focused on identifying medicines to treat Covid-19 patients and developing vaccines to achieve immunity. In 2020, the World Health Assembly called on all parties to guarantee universal access to Covid-19 vaccines. The recent proposal for an international treaty on pandemics builds on this commitment.
Nonetheless, progress on rolling out Covid-19 vaccines has been slow and uneven. Not only are poorer countries paying higher prices for the same Covid-19 vaccines than high-income countries, but they are also struggling to secure much-needed doses at a faster rate.
How can we secure more transparency and accountability across all key points of the Covid-19 vaccine value chain? In this virtual roundtable, we draw from experiences from different experts in the field to discuss how to improve transparency and accountability in areas such as, research and development, procurement and contracting, and distribution.
Daniela Cepeda Cuadradro, U4 Adviser / email@example.com
Mitigating corruption risks in COVID-19 vaccine rollout. What can donors do? (U4 Helpdesk Answer)